Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
about
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression ComorbidityCharacterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal grayThe analgesic potential of cannabinoids.The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.Examining the roles of cannabinoids in pain and other therapeutic indications: a review.Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat.Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses.Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model.The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report.Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.Neural Mobilization Treatment Decreases Glial Cells and Brain-Derived Neurotrophic Factor Expression in the Central Nervous System in Rats with Neuropathic Pain Induced by CCI in Rats.Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells.Electroacupuncture Potentiates Cannabinoid Receptor-Mediated Descending Inhibitory Control in a Mouse Model of Knee Osteoarthritis.Emerging Evidence for Cannabis' Role in Opioid Use Disorder
P2860
Q26784030-676DF7FA-4B16-44CB-A157-37862FDBA366Q33715462-EC939A08-10E1-4401-8489-A5BC321010BCQ34939968-95449C8E-10FB-4A58-A9CB-FC1D86E59167Q36007619-6A5AD994-69C0-4E64-96E4-46363DE1B344Q37057325-5F6D4877-510B-4324-BDE3-C4D59E4837A9Q37646423-2AEA0DCD-160C-4EBB-962F-169772BA91A4Q37650292-41EDE612-BDF6-4B56-9483-CE3F00DB1680Q37710121-31BA31A9-868C-40AB-A6E7-192E332162EAQ37805184-8DD0A0CE-2562-4E17-AB56-457D1DB28502Q39192669-A88D3F9D-EA31-44CE-83E0-4ABDF555C890Q40378596-8462F1F3-F8BD-4A3B-8C45-198292FFFD45Q41178764-ACF571A3-AF13-4745-8C23-581F2D55FB4DQ41782285-143295EC-F28B-4CEB-8CB4-9A428C675FADQ42292804-DEB47565-9EDB-498A-8F59-6F310F4A8292Q42326753-EDA6880F-9B9A-4D0A-AB89-DDD5001CD2D8Q52571509-1238B333-8791-45C0-A8ED-B84F85C2EAA6Q58775143-A2B05C05-361F-45C3-98CA-A00FCFCDCD61
P2860
Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Repeated cannabinoid injection ...... uent morphine antinociception.
@en
Repeated cannabinoid injection ...... uent morphine antinociception.
@nl
type
label
Repeated cannabinoid injection ...... uent morphine antinociception.
@en
Repeated cannabinoid injection ...... uent morphine antinociception.
@nl
prefLabel
Repeated cannabinoid injection ...... uent morphine antinociception.
@en
Repeated cannabinoid injection ...... uent morphine antinociception.
@nl
P2093
P2860
P1433
P1476
Repeated cannabinoid injection ...... uent morphine antinociception.
@en
P2093
Adrianne R Wilson
Lauren Maher
Michael M Morgan
P2860
P304
P356
10.1016/J.NEUROPHARM.2008.07.038
P577
2008-08-05T00:00:00Z